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Centenary theme section: GENODERMATOSES
SIGNIFICANCE
Patients with ichthyosis manifest with dry and scaly skin, 
with considerable phenotypic variability. The heritable 
forms of ichthyosis are associated with mutations in over 
60 different genes which encode proteins critical for normal 
physiological function of the skin. This overview highlights 
some of the new findings in the genetics of heritable forms 
of ichthyosis and emphasizes the connection of skin fin-
dings to extracutaneous manifestations, in some forms of 
the syndromic ichthyosis. The presentation also emphasi-
zes the importance of determining the specific mutations 
in the underlying genes, which allows subclassification of 
the patients into distinct categories, with the capability to 
prognosticate the severity and the overall outcome of the 
disease in general terms. The knowledge of mutations in 
specific genes is also required for application of allele-spe-
cific therapies being developed for this group of disorders 
currently without specific treatments.
The heritable forms of keratinization disorders, inclu-
ding various forms of ichthyosis and keratodermas, 
comprise a phenotypically heterogeneous group of di-
seases which can be divided into syndromic and non-
syndromic forms. In the non-syndromic forms, the 
clinical manifestations are limited to the cutaneous 
structures while the syndromic ones are associated 
with a spectrum of extracutaneous manifestations. 
The inheritance in different families can be autoso-
mal dominant, autosomal recessive or either X-linked 
dominant or recessive. Currently at least 67 distinct 
genes have been associated with different forms of 
ichthyosis. These genes can be grouped on the basis 
of their physiological involvement, including genes en-
coding structural components of epidermis, those in-
volved in epidermal lipid metabolism, or those critical 
for cell-cell adhesion, and keratinocyte differentiation. 
This overview highlights some of the recent progress 
made in understanding the molecular genetics of ke-
ratinization disorders, and presents selected, recent-
ly characterized cases as representative of different 
forms of heritable ichthyosis. 
Key words: autosomal recessive congenital ichthyosis; ichthyo-
sis; non-alcoholic fatty liver disease; non-syndromic ichthyosis; 
syndromic ichthyosis.
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The heritable forms of ichthyosis, also known as generalized Mendelian disorders of cornification 
(MeDOC), comprise a heterogeneous group of diseases 
caused by mutations in a number of genes that are critical 
for development and maintenance of physiologic barrier 
at the outer layer of epidermis (1, 2). Clinically, these 
disorders manifest with scaling and hyperkeratosis of 
varying degrees (Fig. 1). The pathologic findings in the 
patients are either limited to the cutaneous structures or 
are associated with extracutaneous manifestations. Thus, 
ichthyosis can be divided into two broad categories, the 
non-syndromic and the syndromic forms. These disorders 
are present usually at birth or are diagnosed shortly there-
after, but the progression of the disease and the eventual 
outcome of severity can be highly variable. In the most 
severe forms, such as the Harlequin ichthyosis (HI), 
the affected children often die during the early neonatal 
period while at the other end of the spectrum of severity, 
such as ichthyosis vulgaris (IV), the manifestations can 
be relatively mild, the onset of manifestations may occur 
later in life and the spectrum may represent a continuum 
with physiologically present dry skin. The longevity of 
the IV patients is rarely affected by the disease. Also, in 
some cases the scaling and hyperkeratosis present at birth 
can be self-healing within a few months’ timeframe, as 
in so-called self-improving collodion ichthyosis (1–6). 
Various forms of ichthyosis were initially classified 
on the basis of predominant clinical manifestations, and 
early on, different subtypes often carried eponyms of 
the authors of the original descriptions. More recently, it 
has been recognized that clinical heterogeneity, coupled 
with the variable mode of inheritance, i.e., autosomal 
dominant, autosomal recessive, or X-linked dominant or 
recessive, largely reflects the genetic heterogeneity, and 
currently as many as 67 distinct genes have been shown 
to be associated with different forms of ichthyosis. In 
addition, there are as many as 28 mutant genes associa-
ted with palmoplantar keratodermas. Grouping of the 
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genes based on their involvement in distinct biological 
pathways required for physiological differentiation of ke-
ratinocytes and maintenance of the epidermal barrier has 
resulted in a more granular classification which allows 
refined diagnostics and nuanced prognostication in ge-
neral terms (2). In such classification, specific subgroups 
of syndromic and non-syndromic forms of ichthyosis 
can be recognized, based on identification of mutations 
in genes encoding structural components of epidermis, 
involved in epidermal lipid metabolism or critical for 
cell-cell adhesion and keratinocyte differentiation as 
well as homeostasis, essential for formation of functional 
stratum corneum with uncompromised barrier function. 
NEXT-GENERATION SEQUENCING 
APPROACHES FOR MUTATION DETECTION
As in case of most heritable disorders with extensive 
genetic heterogeneity the identification of mutations in 
different forms of ichthyosis was initially based on PCR 
amplification of exons and flanking intronic sequences 
in candidate genes identified by clinical observations 
or by immunofluorescent and ultrastructural examina-
tion of epidermis. However, with expanding number of 
candidate genes associated with keratinization disorders, 
this approach has proven time-consuming and expensive. 
The PCR-based approaches are rapidly being replaced 
by next-generation sequencing (NGS) techniques, 
including sequencing arrays simultaneously targeting 
multiple disease-associated genes or the use of whole 
exome sequencing (WES) and whole genome sequencing 
(WGS) (7–9). These approaches are assisted by genome-
wide tools, including homozygosity mapping (HM) and 
transcriptome profiling by RNA-seq, which facilitate 
identification and verification of pathogenic mutations 
in affected families (10–13).
EXPANDING MUTATION LANDSCAPE OF NON-
SYNDROMIC KERATINIZATION DISORDERS: 
THE PARADIGM OF ARCI
A subgroup of non-syndromic forms of ichthyosis, 
autosomal recessive congenital ichthyosis (ARCI), is 
clinically divided into different subcategories: (a) Har-
lequin ichthyosis (HI), (b) lamellar ichthyosis (LI), and 
(c) congenital ichthyosiform erythroderma (CIE). HI is a 
rare and often severe form of ARCI caused by mutations 
in the ABCA12, while LI and CIE, with partially overlap-
ping phenotypes, have been associated with mutations 
in a total of 14 distinct genes, many of them involved in 
lipid metabolism and essential for formation of functional 
stratum corneum. The different genetic subtypes were 
initially defined by the genomic locations of the cor-
responding genetic loci (ARCI1-17). The 4th subgroup of 
ARCI comprises phenotypically variable forms of icht-
hyosis which can manifest with marked hyperkeratosis 
at birth, but significant spontaneous improvement during 
infancy can result in a relatively mild disease in the 
Fig. 1. Phenotypic variability in patients with autosomal recessive congenital ichthyosis associated with defects in different genes. Note 
the spectrum of severity in association of specific mutations indicated.
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adulthood (1–5, 14). This group, known as pleomorphic 
ichthyosis (14), consists of clinically distinct conditions, 
such as self-improving collodion ichthyosis, ichthyosis 
prematurity syndrome and congenital ichthyosis with 
fine/mild scaling (5, 7, 8). Bathing-suit ichthyosis, also a 
pleomorphic ichthyosis, is a condition in which arms and 
legs are not affected by abnormal keratinization (15). In 
addition, clinically defined forms of ichthyosis include 
peeling skin syndrome, erythrokeratoderma variabilis 
(EKV), loricrin keratoderma and congenital reticular 
ichthyosiform erythroderma. Ichthyosis is often asso-
ciated with development of palmoplantar 
keratoderma, a heterogeneous group of 
disorders which can also present as dis-
tinct clinical entities without ichthyosis 
(see Thomas & O’Toole, 16).
In a recent study by us, the molecular 
basis of a total of 125 families with di-
agnostic features of ARCI was probed 
by a NGS array targeting 38 genes that 
were at the time known to be associated 
with different forms of ichthyosis (17). 
This approach, assisted by homozygosity 
mapping in this cohort which was charac-
terized by high degree of consanguinity, 
followed by whole transcriptome analysis 
by RNA-Seq, identified definitive pat-
hogenic/likely pathogenic mutations in 
approximately 85% of the families (for 
examples, see Fig. 2). Similar results 
have been reported in studies examining 
regional cohorts of families with ARCI, 
including patients in Czech Republic, 
England, Israel, Italy, Turkey and the 
Scandinavian countries (17–22). While 
some differences in the prevalence of 
mutations in different genes were obser-
ved in different cohorts, mutations in the 
TGM1 gene encoding transglutaminase 1, 
as well as in a number of genes involved 
in lipid metabolism (ABCA12, ABHD5, 
ALOX12B, ALOXE3, CERS3 and PN-
PLA1) were frequently encountered (23, 
24). In some populations, PNPLA1 and 
CERS3 mutations are very rare while in 
others, particularly those with high degree 
of customary consanguinity, the propor-
tion of these two genes was relatively high 
(25–29). Interestingly, while ABCA12 
was initially associated with severe, of-
ten lethal HI, mutations in this gene can 
also be encountered in LI and CIE (30). 
It should be noted that many of the muta-
tions found in different genes are private 
and population-specific, em phasizing the 
importance of ethnic-based molecular 
diag nostics when assessing its impact on the public health 
in different countries and geographic regions.
The most recent discoveries of ARCI-associated genes 
include SDR9C7 and SULT2B1. Initially described in 
2016 in affected members of 3 consanguineous Lebanese 
families with congenital ichthyosis, SDR9C7 was map-
ped to chromosome 12q13-q14 (ARCI13) (29). This gene 
encodes short-chain dehydrogenase/reductase family 9C 
member 7 (SDR9C7) and is highly expressed in the gra-
nular and cornified layers of the epidermis. Subsequently, 
a 1-bp duplication co-segregated in a Turkish family 
Fig. 2. Utility of RNA-based sequencing in identification and confirmation of a 
homozygous synonymous/splice-site mutation in TGM1 (Patient-1) and a non-
canonical splicing variant in PNPLA1 in Patient-2. (a1) The proband, a female at 
neonate age (left panel) and at 3 years of age (right panel) showing extensive scaling and 
hyperkeratosis, harboring a mutation in TGM1. (a2) A 4-year-old female with generalized 
fine scaling and hyperlinearity of face harboring a mutation in PNPLA1. (b1) Screen shot 
of the genomic sequence visualized by the Integrative Genomics Viewer demonstrating 
a homozygous mutation of TGM1: c.1491G>A at the border of exon10/intron 10 (upper 
panel). Sashimi plot of RNA-Seq reveals that this homozygous synonymous mutation 
results in aberrant splicing and partial intron retention (lower panel, red), as compared to 
splicing in control RNA (blue). (b2) Screen shot of the genomic sequence visualized by the 
Integrative Genomics Viewer demonstrating a homozygous intronic mutation of PNPLA1: 
IVS1, c.205+5G>A (upper panel). Sashimi plot of RNA-Seq reveals that the homozygous 
non-canonical mutation in intron 1 results in the absence of PNPLA1 transcript (lower panel, 
red) as a result of possible loss of promoter and/or nonsense-mediated decay, as compared 
to an age- and sex- matched control (blue). (c1) Mean average-plot showing reduction of 
TGM1 gene expression (left panel) in Patient 1 (fold change: –1.4), and (c2) reduction of 
PNPLA1 gene expression (right panel) in Patient 2 (fold change: –4.5) in comparison to 
control. (Modified from ref. 17, with permission).
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was discovered, and as many as 14 mutations 
have now been reported in populations in Austria, 
Denmark, France, Germany, Iran, Japan, Sweden, 
Turkey and the United Kingdom (17, 31–34). Of 
note, presence of persistent fungal infection was 
frequently observed in these patients, suggesting 
that the functional SDR9C7 may physiologically 
provide protection against such infections. 
Mutations in another gene, SULT2B1, were 
initially described in 2017 both in homozygous 
and compound heterozygous state, mapping to 
19q13.3 (ARCI14) in 6 patients from 3 unrelated 
families (35). Subsequently, two missense mu-
tations in two unrelated families were reported 
by us (Fig. 3) (17). The SULT2B1 gene encodes 
a sulfotransferase family cytosolic 2B member 
1, expressed in the stratum granulosum-stratum 
corneum junction in the epidermis.
THE PHENOTYPIC SPECTRUM OF 
SYNDROMIC FORMS OF ICHTHYOSIS: 
THE SKIN-LIVER CONNECTION
While the consequences of the mutations in non-
syndromic forms of ichthyosis are limited to the 
skin, a number of cases with cutaneous keratini-
zation disorder in association with 
extracutaneous manifestations have 
been reported (1, 2, 36). In such con-
ditions, the pathway disrupted by the 
mutations in specific genes have con-
sequences not only in the homeostasis 
of epidermis but also in a number of 
other tissues. As examples of such 
conditions serve two syndromes, 
neonatal ichthyosis associated with 
sclerosing cholangitis (NISCH) and 
Chanarin-Dorfman syndrome (CDS), 
in which in addition to skin, liver 
can be affected (37, 38). The NISCH 
syndrome is initially diagnosed with 
relatively mild ichthyosis at birth, 
and histology reveals thickening of 
stratum corneum at the outer layer of 
the epidermis (Fig. 4). Extracutaneous 
manifestations include hypotrichosis, 
scarring alopecia, hypodontia and ena-
mel hypoplasia, but a critical element 
of this syndrome is the involvement 
of liver with sclerosing cholangitis 
diagnosed later in life on the basis 
of hepatomegaly and elevated serum 
levels of liver enzymes. Mutations in 
the CLDN1, which encodes the tight 
Fig. 3. Utility of homozygosity mapping in gene discovery in a consanguineous family with 
a SULT2B1 mutations. (a) The proband, a 32-year-old woman, demonstrated extensive scaling 
present since birth and hirsutism due to mutations in SULT2B1. (b) Pedigree of the three affected 
individuals with first cousin parents. Histopathology of the proband’s skin shows characteristic 
features of LI. (c) Autosome wide homozygosity mapping identified a region of homozygosity present 
in all 3 affected individuals (IV-1, 3, 4), but not in their parents (III-1, 2), on chromosome 19. This 
region harbored the locus for the SULT2B1 gene, and Sanger sequencing identified a homozygous 
mutation c.232G>A, p.Glu78Lys, as shown in (b). (Modified from ref. 17, with permission).
Fig. 4. Clinical features and mutation detection in a consanguineous family 
with NISCH syndrome with claudin-1 deficiency. (a) The patients with fine scaly 
ichthyosis and alopecia, oligodontia and enamel hypoplasia. (b) Family pedigree 
of the affected individuals with consanguineous parents. (c) Gene-targeted next-
generation sequencing identified an ultra-rare homozygous p.Tyr159Ter mutation 
in the patients, verified by Sanger sequencing, the parents being heterozygous 
carriers (red arrows). (d) Positions of the novel p.Tyr159Ter mutation (red) and 
those previously reported in the CLDN1 gene (black). NISCH, Neonatal ichthyosis 
associated with sclerosing cholangitis. (Modified from ref. 37, with permission).
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junction protein claudin-1, has been reported in a limited 
number of patients with NISCH syndrome (Fig. 4). Thus, 
congenital presentation of ichthyotic skin lesions together 
with mutations in CLDN1 as the molecular confirmation 
of NISCH syndrome can predict the development of 
sclerosing cholangitis and liver abnormalities. 
In addition to NISCH syndrome, other forms of 
ichthyosis are associated with liver involvement. An 
example of such conditions is Chanarin-Dorfman syn-
drome (CDS) characterized by hepatomegaly and hepatic 
steatosis, in association with ichthyosis which is readily 
recognizable during early years of life due to mutations 
in ABHD5 (Fig. 5). Full-blown CDS with skin and liver 
findings is inherited in an autosomal recessive fashion 
due to loss-of-function mutations in ABHD5 (39, 40). 
The liver involvement often progresses to hepatic stea-
tosis, liver fibrosis and cirrhosis, and may necessitate 
liver transplant. 
An intriguing genetic constellation was recently re-
cognized in heterozygous carriers of ABHD5 mutations 
in CDS families (40). Specifically these individuals had 
diagnostic features of dyslipidemia and non-alcoholic 
fatty liver disease (NAFLD), a multifactorial condition 
and the most common liver disease worldwide, affecting 
up to one-third of the Western populations (41, 42). The 
monoallelic loss-of-function mutations, identified in 
consanguineous families with CDS, resulted in NAFLD 
in an autosomal dominant inheritance pattern, which was 
confirmed in a large multi-generation family without 
consanguinity and with no individuals with biallelic 
mutations (40). These patients with the heritable form 
of NAFLD and/or dyslipidemia demonstrated complete 
clinical expression after the 4th decade of life, and the pre-
valence of ABHD5-associated NAFLD was estimated to 
be 1:1,137 individuals in general populations (40). Thus, 
mutations in ABHD5, which is involved in neutral lipid 
Fig. 5. Pedigree structures and clinical findings in NAFLD families with ABHD5 mutations. (a) Family 1 is of nonconsanguineous Italian ancestry 
with a monoallelic mutation in ABHD5. Families 2–7 of Iranian ancestry with Chanarin-Dorfman syndrome (CDS) show extensive consanguinity. Heterozygous 
carriers (+/−) show evidence of NAFLD and/or dyslipidemia and type 2 diabetes mellitus, and patients with biallelic mutations (+/+) manifest with CDS 
with neonatal ichthyosis and NAFLD. Individuals labeled with § are considered obligatory carriers of the mutation. For the presence of clinical manifestations 
in individuals tested, see the color code. (b) Sanger sequencing of mutations in Families 1–6. The mutation of Family 7, ABHD5:c.560_578 del19 was 
published previously (61). (c) Positions of the distinct mutations along the ABHD5 consisting of 7 exons drawn to scale; the introns are not in scale. (d) 
Presence of lipid droplets (red) in leukocytes from control (upper panels), a heterozygous carrier (middle panel), and a homozygous individual (lower 
panel) after incubation without (-OA, left) or with 200 µM oleic acid (+OA, right). The lipid content was quantitated by assay of the pixel density of Oil 
red O and DAPI stained cells (bar graph). The values represent the mean ± SD of 105–125 cells for each sample. CDS, Chanarin-Dorfman syndrome; 
NAFLD, non-alcoholic fatty liver disease; OA, oleic acid; UTR, untranslated region. (Adapted from ref. 40, with permission).
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metabolism, emphasize the pathogenic role of lipid dis-
orders both in NAFLD and in some forms of ichthyosis. 
Recent independent studies corroborated the role of 
CGI-58 (encoded by ABHD5) and its partners, such as 
adiponutrin (encoded by PNPLA3) and ATGL (encoded 
by PNPLA2), in the pathogenesis of NAFLD. First, Ro-
meo et al. (43) carried out a genome-wide association 
study (GWAS) of 9,229 individuals with NAFLD, and 
they found that a common SNP (rs738409[G]), encoding 
p.I148M in PNPLA3, was strongly associated with in-
creased hepatic fat content (43). These observations have 
been supported by other studies. For example, Wang et al. 
showed a direct protein-protein interaction of CGI-58 and 
adiponutrin (44). In addition, they showed that normal 
PNPLA3 overexpression does not enhance lipid accumu-
lation in primary hepatocytes derived from liver-specific 
Abhd5-knockout mice, thus again suggesting that PNP-
LA3 mediates ABHD5-dependent liver steatosis. Finally, 
Yang et al. showed that PNPLA3-I148M allele product 
in carriers attaches to and sequesters CGI-58 preventing 
its association with ATGL (Adipose Triglyceride Lipase) 
in a competitive inhibition fashion 
(45, 46). ATGL, when associated 
and activated by CGI-58, is required 
for the breakdown of triglycerides 
in the liver and adipose tissue. Thus, 
in the absence of ATGL available 
for binding to CGI-58, due to se-
questration by PNPLA3-I148M in 
carriers, triglycerides accumulate 
in the liver providing a pathome-
chanistic explanation for hepatic 
steatosis in NAFLD (47). 
GENETIC DEFECTS IN 
CELL-CELL ADHESION AND 
COMMUNICATION
In addition to claudin-1, a trans-
membrane protein in the tight jun-
ction complexes which regulates 
para-cellular permeability in the 
epidermis (see above), mutations 
in other genes involved in cell-cell 
communication have also been 
associated with aberrant keratini-
zation phenotypes. One of such 
is GJB2 encoding connexin 26, 
previously shown to be mutated 
in KID syndrome and some forms 
of palmoplantar keratoderma (see 
Thomas & O’Toole, 16). Icht-
hyosis follicularis is a distinct 
keratinization disorder which has 
been reported in association with 
atrichia and photophobia resulting 
from mutations in the MBTPS2 gene (48). Recently, ho-
wever, compound heterozygous mutations in the GJB2 
gene were reported in a novel syndrome of ichthyosis 
follicularis, bilateral sensorineural hearing loss and 
punctate palmoplantar keratoderma (10) (Fig. 6). One 
of the mutations (p.Asn176Asp) was demonstrated to 
significantly reduce the cell-cell gap junction channel 
activity and to increase the non-junctional hemichannel 
activity of connexin 26 when tested in Xenopus oocyte 
expression system (10). This mutation, when associated 
with a common frameshift mutation in GJB2 (c.35delG; 
p.Gly12Valfs*2), frequently documented as a cause of 
sensorineural hearing loss, resulted in manifestations 
of this new syndrome, including ichthyosis follicularis 
phenotype. Collectively, these findings, coupled with 
previous reports on GJB2 associations with skin findings, 
attest to the complexity of clinical consequences of dif-
ferent mutations in GJB2. 
A number of other genes contributing to cell-cell ad-
hesion and communication have been associated with 
syndromic forms of keratinization disorders. For example, 
Fig. 6. Example of a novel GJB2-associated syndromic form of ichthyosis. Pedigree structure, 
cutaneous features, histopathology, alteration of the magnetic field and mutations in GJB2 in families 
with autosomal recessive follicular hyperkeratosis, PPK, and bilateral sensorineural deafness. (a1, 
a2) Family pedigrees with autosomal recessive inheritance. (b1, b2) Histopathology of a skin lesion 
delineated in (b1) revealed a parakeratotic column of hyperkeratotic skin invaginating into epidermis. 
(c1 and c2). Palm of the proband (IV-1) with hyperkeratosis and accentuated creases which contain 
punctate pits. (d) Multiple discrete hyperkeratotic projections are centering on hair follicle in widespread 
distribution, including legs. (e and g). Filtering steps of whole exome sequencing data resulted in 
identification of compound heterozygous p.Asn176Asp and c.35delG mutations in GJB2, followed by 
Sanger sequencing confirmation. (f) Modeled structure of Cx26 gap junction channels in wild-type 
(left) and mutant p.Asn176Asp (right). Note the alteration in positive (blue) and negative (red) 
electrostatic potentials. (Modified from ref. 10, with permission).
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the desmosomal proteins JUP and DSP have both been 
associated with cardiomyopathy, but cutaneous manifes-
tations, such as palmoplantar keratoderma or hair abnor-
malities, are highly variable depending on the mutation 
involved (49, 50). More recently, it was demonstrated that 
alterations in PERP, another component of desmosomes 
can cause an autosomal dominant Olmsted syndrome 
or autosomal recessive erythrokeratoderma (51). This 
observation underscores the genotypic and phenotypic he-
terogeneity of keratinization disorders: PERP mutations 
confer a spectrum of phenotypes ranging from severe 
periorificial plaques and palmoplantar keratoderma, as 
seen in patients with TRPV3 mutations (52), to varying 
degrees of erythrokeratoderma observed in patients with 
mutant GJB3, GJB4, and LOR genes (53–55).
The PERP gene consists of 3 exons encoding the 
p53/p63 tetraspan membrane protein that is expressed 
primarily in stratified epithelia (56, 57). Although the 
exact interacting partners of PERP are still unknown, its 
importance in cell-cell adhesion and epithelial integrity 
was implied by the observation that the majority (95%) 
of Perp knockout (–/–) mice died within 10 days of life 
due to blistering in the oral mucosa and skin, especially 
in areas of mechanical trauma, but also showed abnormal 
thickening of the epidermis (57). The 5% of Perp–/– mice 
that survived to adulthood had a significantly shorter 
lifespan compared to Perp+/– and wild-type mice and did 
not show a predisposition to spontaneous tumorigenesis 
despite evidence linking p53/p63 to Perp expression (56, 
58). Nevertheless, with documentation of these cases 
with PERP mutations in humans, clinicians should be 
aware of this connection and monitor patients accor-
dingly for potential evidence of carcinogenesis. 
GENETIC DEFECTS ASSOCIATED WITH 
KERATO DERMAS: THE PARADIGM OF 
ERYTHROKERATODERMA
Erythrokeratoderma manifests with hyperkeratotic, often 
transient and migratory erythematous and figurate plaqu-
es with sharply demarcated borders typically developing 
in early childhood (Fig. 7). It has been historically divi-
ded into two main categories: (a) erythrokeratodermia 
variabilis et progressiva; and (b) progressive symmetric 
erythrokeratoderma. However, these two presentations 
are currently listed on the OMIM catalogue under a single 
disease entry (OMIM #133200). There are a number of 
other presentations with erythrokeratoderma (59). Ery-
throkeratoderma can be inherited either in an autosomal 
dominant or an autosomal recessive pattern. The autoso-
mal dominant forms have been associated with mutations 
in the gap junction-related genes (GJB2, GJB3, GJB4, 
and GJA1) as well as in LOR, encoding loricrin, a corni-
fied envelope protein (53–55, 59). Autosomal recessive 
erythrokeratoderma has been associated with mutations 
in ABHD5, ELOVL4 and KDSR. More recently, the geno-
typic spectrum of erythrokeratoderma has been extended 
by application of NGS using ichthyosis-associated gene 
sequencing panels which identified mutations in addition 
to those previously identified genes, also in PNPLA1 in 
Fig. 7. Patients with ichthyosis 
a n d  d i f f e r e n t  g e n e t i c 
mutations presenting with 
erythrokeratoderma. (a) Patient 
1, a 2-year-old female patient 
with erythrokeratoderma and a 
homozygous missense mutation 
in the ABHD5 gene consistent 
with Chanarin-Dorfman syndrome. 
(b) Patient 2, a 7-year-old male 
with erythrokeratoderma and 
generalized ichthyosis due to a 
missense mutation in PNPLA1. (c) 
Patient 3, a 12-year-old female with 
extensive erythrokeratoderma and 
large brown ichthyotic plaques on 
the face, consistent with autosomal 
recessive ichthyosis associated 
with mutations in PNPLA1. Sanger 
sequencing confirmed the out-of-
frame deletion of 13 bp, shown in 
yellow (lower right panel) (Modified 
from ref. 57, with permission).
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families with the autosomal recessive form of erythroke-
ratoderma (Fig. 7) (10). These studies provide evidence 
in support of the notion that erythrokeratoderma can be 
a manifestation associated with multiple types of icht-
hyosis with different gene defects (60). Consequently, 
erythrokeratoderma may not be a distinct genetic entity 
but rather a manifestation of multiple ichthyosis-related 
genetic diseases that can occur with or without a more 
typical ichthyosis presentation.
CONCLUSIONS
This update on recent advances in our understanding 
the molecular basis of heritable keratinization disorders 
highlights the tremendous variability, both phenotypic 
and genotypic, in this group of disorders. The knowledge 
of the mutant genes and of specific mutations can be used 
to confirm the diagnosis with subclassification, allows 
determination of the mode of inheritance, and provides 
information for prognostication, in general terms, of the 
severity and overall outcome of the disease. The mutation 
detection in large consanguineous families also allows 
identification of heterozygous carriers which can be 
coupled with genetic counseling for the risk of recurrence 
in the extended family. The mutations form the basis for 
prenatal testing and preimplantation genetic diagnosis. 
Finally, the knowledge of the specific mutations is a 
prerequisite for allele-specific treatments currently being 
developed for this group of complex disorders without 
specific treatment modalities.
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